Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rosamaria Silipigni
Mass Spectrometry-Based Assay for the Molecular Diagnosis of Glioma: Concomitant Detection of Chromosome 1p/19q Codeletion, and IDH1, IDH2, and TERT Mutation Status
Oncotarget
Oncology
Related publications
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status.
Clinical Cancer Research
Cancer Research
Oncology
CDKN2C Homozygous Loss Identifies a Distinct Subtype of TP53/RB1-wildtype Leiomyosarcoma With Frequent CIC Genomic Alterations and 1p/19q-Codeletion
Assessment of 1p/19q Deletion by Flourescence Insitu Hybridization (FISH) in Glioma Patients From Andhrapradesh
Molecular Cytogenetics
Biochemistry
Molecular Medicine
Genetics
Molecular Biology
IDH1 Mutation Diminishes Aggressive Phenotype in Glioma Stem Cells
International Journal of Oncology
Cancer Research
Oncology
IDH1 R132H Mutation Regulates Glioma Chemosensitivity Through Nrf2 Pathway
Oncotarget
Oncology
IDH1/2 Mutation Status Combined With Ki-67 Labeling Index Defines Distinct Prognostic Groups in Glioma
Oncotarget
Oncology
Molecular and Mass Spectrometry Detection and Identification of Causative Agents of Bloodstream Infections
Imaging Correlates for the 2016 Update on WHO Classification of Grade II/III Gliomas: Implications for IDH, 1p/19q and ATRX Status
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
